Drug Profile
Research programme: osteoporosis therapies - Avecho Biotechnology
Alternative Names: Parathyroid hormone fragments - Avecho Biotechnology; TPM 01/PTHLatest Information Update: 29 Dec 2020
Price :
$50
*
At a glance
- Originator Phosphagenics
- Class Peptide hormones
- Mechanism of Action Parathyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 24 Aug 2005 Preclinical trials in Osteoporosis in Australia (Transdermal)